Suraksha Diagnostic Public Issue Set To Open on November 29

Suraksha Diagnostic’s ₹846.25 crore-worth IPO is set to open on November 29, 2024 and closes on December 02, 2024. The IPO is entirely an offer for the sale of 1.92 crore shares. Suraksha Diagnostic allotment is likely to be finalised on December 4, 2024, and will be tentatively listed on December 6, 2024. Suraksha Diagnostic IPO price band has been set at ₹420 to ₹441 per share. A retail investor is required to make a minimum investment of ₹14,994 for a minimum of 1 lot having 34 shares.

Suraksha Diagnostic Limited has appointed ICICI Securities Limited, Nuvama Wealth Management Limited and SBI Capital Markets Limited as the book-running lead managers, while Kfin Technologies Limited as the registrar for the issue.

Objective of Suraksha Diagnostic

Suraksha Diagnostic will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.

About Suraksha Diagnostic Limited

Suraksha Diagnostic Limited was incorporated in 2005. The company offers pathology, radiology testing and medical consultancy services. As of June 30, 2024, the company operates a central reference laboratory with 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres across West Bengal, Bihar, Assam, and Meghalaya. Suraksha Diagnostic offers its customers online and offline medical consultation services under one roof via 44 diagnostic centres, which house 120 polyclinics with more than 750 doctors.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.